Evelo Biosciences Inc (EVLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Operating Expenses | 11,183 | 19,574 | 24,900 | 21,087 | 29,054 |
| Operating Income | -11,183 | -19,574 | -24,900 | -21,087 | -29,054 |
| Interest Expense | 1,162 | 1,369 | 1,111 | 1,837 | 788 |
| Other Income | -36 | 73 | 815 | -73 | -615 |
| Pre-tax Income | -12,381 | -20,870 | -25,196 | -22,997 | -30,457 |
| Income Tax | -17 | 233 | 145 | 544 | 107 |
| Net Income Continuous | -12,364 | -21,103 | -25,341 | -23,541 | -30,564 |
| Net Income | $-12,364 | $-21,103 | $-25,341 | $-23,541 | $-30,564 |
| EPS Basic Total Ops | -0.71 | -3.78 | -4.60 | -1.27 | -5.66 |
| EPS Basic Continuous Ops | -0.71 | -3.78 | -4.57 | -1.41 | -5.66 |
| EPS Diluted Total Ops | -0.71 | -3.78 | -4.60 | -1.27 | -5.66 |
| EPS Diluted Continuous Ops | -0.71 | -3.78 | -4.57 | -1.41 | -5.66 |
| EPS Diluted Before Non-Recurring Items | -0.66 | -3.55 | -4.60 | -4.20 | -5.60 |
| EBITDA(a) | $-11,014 | $-19,150 | $-24,455 | $-20,564 | $-28,567 |